Fever and lymphadenopathy. Report of 4 cases of tularemia

被引:6
作者
Bloch, C. [1 ]
Friedl, A. [2 ]
Zucol, F. [3 ]
Widmer, A. [1 ]
Khanna, N. [1 ]
机构
[1] Univ Spital Basel, Klin Infektiol & Spitalhyg, CH-4031 Basel, Switzerland
[2] Kantonsspital Baden, Baden, Switzerland
[3] Kantonsspital Winterthur, Dept Kinder & Jugendmed, Winterthur, Switzerland
来源
INTERNIST | 2013年 / 54卷 / 04期
关键词
Tularemia; Zoonosis; Ticks; Disease vectors; Ciprofloxacin; OUTBREAK; AGENTS; SWEDEN;
D O I
10.1007/s00108-013-3254-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report on 4 patients with different types of tularemia acquired in Switzerland or nearby countries. All patients presented with fever, moderate to highly elevated signs of inflammation, and local lymphadenopathy. Additionally, 3 patients did not respond to empirical antimicrobial therapy with aminopenicillins. A tick bite was identified as mode of transmission in 2 patients, while 1 patient showed a possible connection to a tick bite. The route of transmission for the fourth patient remained unknown. The diagnosis of tularemia was either based on positive serology, on a positive polymerase chain reaction (PCR) from the lymph node samples or on positive blood cultures. The treatment in adult patients was ciprofloxacin 500-750 mg twice daily orally for 3 weeks. The pediatric patient was treated with gentamicin 4 mg/kg i.v. once daily for 1 week and ciprofloxacin 15 mg/kg twice daily orally for another 2 weeks. All patients recovered completely. Due to the increasing incidence of tularemia in Switzerland, this infection should be considered in patients with fever and lymph node enlargement particularly after tick bite. We recommend treatment with ciprofloxacin orally for 14-12 days.
引用
收藏
页码:491 / 497
页数:7
相关论文
共 10 条
[1]   The 2000 tularemia outbreak:: A case-control study of risk factors in disease-endemic and emergent areas, Sweden [J].
Eliasson, H ;
Lindbäck, J ;
Nuorti, JP ;
Arneborn, M ;
Giesecke, J ;
Tegnell, A .
EMERGING INFECTIOUS DISEASES, 2002, 8 (09) :956-960
[2]   Tularaemia in an emergent area in Sweden:: An analysis of 234 cases in five years [J].
Eliasson, Henrik ;
Back, Erik .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 39 (10) :880-889
[3]   STREPTOMYCIN AND ALTERNATIVE AGENTS FOR THE TREATMENT OF TULAREMIA - REVIEW OF THE LITERATURE [J].
ENDERLIN, G ;
MORALES, L ;
JACOBS, RF ;
CROSS, JT .
CLINICAL INFECTIOUS DISEASES, 1994, 19 (01) :42-47
[4]   An outbreak of primary pneumonic tularemia on martha's vineyard [J].
Feldman, KA ;
Enscore, RE ;
Lathrop, SL ;
Matyas, BT ;
McGuill, M ;
Schriefer, ME ;
Stiles-Enos, D ;
Dennis, DT ;
Petersen, LR ;
Hayes, EB .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) :1601-1606
[5]   LANDMARK ARTICLE - TULAREMIA (REPRINTED) [J].
FRANCIS, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (23) :3216-3224
[6]  
Johansson A, 2000, J CLIN MICROBIOL, V38, P22
[7]   Tularemia epidemic in northwestern Spain:: Clinical description and therapeutic response [J].
Pérez-Castrillón, JL ;
Bachiller-Luque, P ;
Martín-Luquero, M ;
Mena-Martín, FJ ;
Herreros, V .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (04) :573-576
[8]   Public health assessment of potential biological terrorism agents [J].
Rotz, LD ;
Khan, AS ;
Lillibridge, SR ;
Ostroff, SM ;
Hughes, JM .
EMERGING INFECTIOUS DISEASES, 2002, 8 (02) :225-230
[9]   In vitro susceptibility of isolates of Francisella tularensis types A and B from North America [J].
Urich, Sandra K. ;
Petersen, Jeannine M. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (06) :2276-2278
[10]   Clinical Recognition and Management of Tularemia in Missouri: A Retrospective Records Review of 121 Cases [J].
Weber, Ingrid B. ;
Turabelidze, George ;
Patrick, Sarah ;
Griffith, Kevin S. ;
Kugeler, Kiersten J. ;
Mead, Paul S. .
CLINICAL INFECTIOUS DISEASES, 2012, 55 (10) :1283-1290